Press release available only in original language.
Amsterdam, the Netherlands and New York, NY – On the occasion of the 73rd Session of the United Nations General Assembly (UNGA 73), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful development of the ‘Augmented Infant Resuscitator (AIR)’ – an add-on device for conventional neonatal bag-valve-mask (BVM) resuscitators that helps care givers to effectively resuscitate asphyxiated newborn babies. Developed in collaboration with the Consortium for Affordable Medical Technologies(CAMTech) at Massachusetts General Hospital Global Health, the #philips Augmented Infant Resuscitator aims to reduce neonatal mortality, especially in parts of the world that are underserved in terms of healthcare. It is expected to be available in limited volume in selected markets prior to scaling up availability in low- and middle-income countries.
Birth asphyxia’s global impact
Birth asphyxia is a medical condition caused by prolonged deprivation of oxygen to a newborn during the birth process, resulting in damage to vital organs, usually the baby’s brain. Globally, birth asphyxia causes more than 800,000 neonatal deaths annually, and over one million potentially preventable reported stillbirths. Effective resuscitation could reduce birth asphyxia related neonatal deaths by 30 percent, and deaths from prematurity by 10 percent. However, one-in-five trained healthcare professionals fail to perform the resuscitation technique correctly, and those that do often experience a rapid decline in proficiency.
Further information in the press release to download
© Copyright 2024